1. Home
  2. TCX vs PLX Comparison

TCX vs PLX Comparison

Compare TCX & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$20.32

Market Cap

233.3M

Sector

Technology

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.74

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCX
PLX
Founded
1992
1993
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3M
204.9M
IPO Year
1996
1998

Fundamental Metrics

Financial Performance
Metric
TCX
PLX
Price
$20.32
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
29.5K
560.5K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$384,728,000.00
$61,840,000.00
Revenue This Year
N/A
$14.29
Revenue Next Year
N/A
$16.65
P/E Ratio
N/A
$25.34
Revenue Growth
8.03
35.41
52 Week Low
$13.27
$1.32
52 Week High
$23.38
$3.10

Technical Indicators

Market Signals
Indicator
TCX
PLX
Relative Strength Index (RSI) 47.72 38.71
Support Level $20.63 $1.68
Resistance Level $22.26 $1.78
Average True Range (ATR) 0.92 0.09
MACD -0.18 0.01
Stochastic Oscillator 17.66 43.48

Price Performance

Historical Comparison
TCX
PLX

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: